Earnings History Data for Genmab A/S (GMAB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Genmab A/S

Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
16-02-2022 AH GMAB Genmab A/S 21,570 0.17 0.15 0.14 32.70 -0.84 
(-2.50%)
33.73 0.19 
(0.57%)
30.10 - 49.07 850,430 690,000 4,920
05-05-2021 PM GMAB Genmab A/S 24,180 0.27 0.04 0.06 Genmab A/S reports Q1 results
[5/5/2021 11:30 AM]
37.22 0.54 
(1.47%)
37.22 0.0 
(0.00%)
24.83 - 44.83 402,801 430,000 1,738
23-02-2021 PM GMAB Genmab A/S 25,070 0.14 0.12 0.34 Genmab A/S beats on revenue
[2/23/2021 12:43 PM]
33.70 -1.43 
(-4.07%)
34.89 -0.24 
(-0.68%)
16.24 - 44.83 1,154,404 661,961 19,344
04-11-2020 PM 0:00 AM ET
(Nov 4)
GMAB Genmab A/S 22,250 0.13 0.08 1.26 Genmab A/S EPS beats by DKK1.88, beats on revenue
[11/4/2020 1:56 PM]
39.43 1.40 
(3.68%)
39.43 0.0 
(0.00%)
16.24 - 39.79 561,682 585,053 1,446
12-08-2020 AH GMAB Genmab A/S 23,500 0.76 0.88 0.20 38.08 1.70 
(4.68%)
37.01 0.63 
(1.73%)
16.24 - 38.28 632,558 565,030 18,593